Protocol Version Date:
Principal Investigator:
Application No:
Page 1 of 8
Patient I.D. Plate
RESEARCH INFORMED CONSENT/PARENTAL PERMISSION FORM for
Title:
If you are a parent or legal guardian of a child who may take part in this study, permission from you is required. The assent (agreement) of your child may also be required. When we say “you” in this consent form, we mean you or your child; “we” means the doctors and other staff.
W
HY AM
I
BEING INVITED TO TAKE PART IN THIS STUDY
?
W HY IS THIS STUDY BEING DONE ?
W HAT WILL HAPPEN ON THIS STUDY THAT IS RESEARCH ?
C AN I STOP BEING IN THE STUDY ?
Yes. You can decide to stop at any time. Tell the doctor if you are thinking about stopping or decide to stop. He or she will tell you how to stop safely.
It is important to tell the doctor if you are thinking about stopping so any risks from the treatment can be evaluated by your doctor. Another reason to tell your doctor that you are thinking about stopping is to discuss what follow-up care and testing could be most helpful for you.
The doctor may stop you from taking part in this study at any time if he/she believes it is in your best interest; if you do not follow the study rules; or if the study is stopped.

Protocol Version Date:
Page 2 of 8
W
HAT SIDE EFFECTS OR RISKS CAN
I
EXPECT FROM BEING IN THE STUDY
?
You may have side effects while on the study. Everyone taking part in the study will be watched carefully for any side effects. However, doctors don’t know all the side effects that may happen. Side effects may be mild or very serious. Your health care team may give you medicines to help lessen side effects. Many side effects go away soon after you stop taking the chemotherapy, although in some cases there are prolonged or even permanent side effects from stem cell transplantation. In some cases, side effects can be serious, long lasting, or may never go away. There also is a risk of death from the treatment.
You should talk to your doctor about any side effects that you have while taking part in the study.
A RE THERE BENEFITS TO TAKING PART IN THE STUDY ?
W HAT OTHER CHOICES DO I HAVE IF I DO NOT TAKE PART IN THIS STUDY ?
Your other choices may include:

Getting treatment or care for your cancer without being in a study

Taking part in another study

Getting no treatment

Getting comfort care, also called palliative care. This type of care helps reduce pain, tiredness, appetite problems and other problems caused by the cancer. It does not treat the cancer directly, but instead tries to improve how you feel.
Comfort care tries to keep you as active and comfortable as possible.
Talk to your doctor about your choices before you decide if you will take part in this study.
H OW MANY PEOPLE WILL TAKE PART IN THE STUDY ?
H
OW LONG IS THE STUDY
?
W HAT ARE THE COSTS ?
You or your insurance company will be charged for continuing medical care and/or hospitalization.
For more information on clinical trials and insurance coverage, you can visit the National
Cancer Institute’s Web site at: http://www.cancer.gov/clinicaltrials/learningabout/payingfor
You can print a copy of the “Clinical Trials and Insurance Coverage” information from this
Web site.
Another way to get the information is to call 1-800-4-CANCER (1-800-422-6237) and ask them to send you a free copy.

Protocol Version Date:
Page 3 of 8
W HAT ARE MY RIGHTS AS A PARTICIPANT ?
Taking part in this study is your choice. You may choose either to take part or not to take part in the study. If you decide to take part in this study, you may leave the study at any time.
No matter what decision you make, there will be no penalty to you and you will not lose any of your regular benefits. Leaving the study will not affect your medical care. You can still get your medical care from our institution.
We will tell you about new information or changes in the study that may affect your health or your willingness to continue in the study.
H OW WILL YOUR PRIVACY BE PROTECTED ?
We have rules to protect information about you. Federal and state laws and the federal medical Privacy Rule also protect your privacy. By signing this form you provide your permission, called your “authorization,” for the use and disclosure of information protected by the Privacy Rule.
The research team working on the study will collect information about you. This includes things learned from the procedures described in this consent form. They may also collect other information including your name, address, date of birth, and information from your medical records. This could include information about HIV and genetic testing, or treatment for drug or alcohol abuse or mental health problems.
The research team will know your identity and that you are in the research study. Other people at Johns Hopkins, particularly your doctors, may also see or give out your information.
We make this information available to your doctors for your safety. If you think this study might affect your clinical care, please inform your doctor .
People outside of Johns Hopkins may need to see or receive your information for this study.
Examples include government agencies (such as the Food and Drug Administration), safety monitors, other sites in the study and companies that sponsor the study.
Organizations that may look at and/or copy your medical records for research, quality assurance, and data analysis include:
 The Children’s Oncology Group

National Cancer Institute (NCI) Clinical Trials Cooperative Groups

Representatives of the NCI, Food and Drug Administration (FDA), and

Other U.S. and international governmental regulatory agencies involved in keeping research safe for people

The Johns Hopkins Medicine IRB

The Central Institutional Review Board (CIRB) of the National Cancer Institute

The Pediatric Central Institutional Review Board (CIRB) of the National Cancer
Institute

Protocol Version Date:
Page 4 of 8
We cannot do this study without your authorization to use and give out your information. You do not have to give us this authorization. If you do not, then you may not join this study.
We will use and disclose your information only as described in this form and in our Notice of
Privacy Practices; however, people outside Johns Hopkins who receive your information may not be covered by this promise or by the federal Privacy Rule. We try to make sure that everyone who needs to see your information keeps it confidential
– but we cannot guarantee that your information will not be re-disclosed.
The use and disclosure of your information has no time limit. You may revoke (cancel) your permission to use and disclose your information at any time by notifying the Principal
Investigator of this study by phone or in writing. If you contact the Principal Investigator by phone, you must follow-up with a written request that includes the study number and your contact information. The Principal Investigator can be reached by phone at Insert phone number or by sending a letter to:
I NCLUDE BELOW THE NAME , ADDRESS , AND FAX NUMBER OF THE P RINCIPAL I NVESTIGATOR
If you do cancel your authorization to use and disclose your information, your part in this study will end and no further information about you will be collected. Your revocation
(cancellation) would not affect information already collected in the study, or information we disclosed before you wrote to the Principal Investigator to cancel your authorization.
A Certificate of Confidentiality has been obtained for this study from the Department of Health and Human Services (DHHS).
This Certificate provides that the group conducting this study cannot be forced (for example, by court subpoena) to disclose information that may identify you in any federal, state or local civil, criminal, administrative, legislative or other proceeding.
You should know that a Confidentiality Certificate does not prevent you or a member of your family from voluntarily releasing information about you or your involvement in this research. If an insurer or employer learns about your participation and obtains your consent to receive research information, then we may not use the Certificate of Confidentiality to withhold this information. This means that you and your family must also actively protect your privacy.
You should also understand that your doctor and the group conducting this study may take steps, including reporting to authorities, to prevent you from seriously harming yourself or others.
A description of this clinical trial will be available on http://www.ClinicalTrials.gov
as required by U.S. Law. This Web site will not include information that can identify you. At most, the web site will include a summary of the results. You can search this web site at any time.

Protocol Version Date:
Page 5 of 8
W
HAT TREATMENT COSTS WILL BE PAID IF YOU ARE INJURED IN THIS STUDY
?
Johns Hopkins and the federal government do not have programs to pay you if you are hurt or have other bad results from being in the study. However, medical care at Johns Hopkins is open to you as it is to all sick or injured people.

If you have health insurance: The costs for any treatment or hospital care you receive as the result of a study-related injury will be billed to your health insurer. Any costs that are not paid for by your health insurer will be billed to you.

If you do not have health insurance: You will be billed for the costs of any treatment or hospital care you receive as the result of a study-related injury.
By signing this form you will not give up any rights you have to seek compensation for injury.
W HAT OTHER THINGS SHOULD YOU KNOW ABOUT THIS RESEARCH STUDY ? a. W HAT IS THE I NSTITUTIONAL R EVIEW B OARD (IRB) AND HOW DOES IT PROTECT YOU ?
The Johns Hopkins Medicine IRB is made up of:

Doctors

Nurses

Ethicists

Non-scientists

and people from the local community.
The IRB reviews human research studies. It protects the rights and welfare of the people taking part in those studies. You may contact the IRB if you have questions about your rights as a participant or if you think you have not been treated fairly. The IRB office number is 410-955-3008. You may also call this number for other questions, concerns or complaints about the research.
If this study may include participants at Howard County General Hospital, include the following:
If you are a participant at Howard County General Hospital, you may contact Jay
Blackman (IRB office at that site) at 410-740-7720. b. W HAT DO YOU DO IF YOU HAVE QUESTIONS ABOUT THE STUDY ?
Call the principal investigator, Dr. _______ at insert telephone number. If you wish, you may contact the principal investigator by letter or by fax. The address and fax number are on page one of this consent form. If you cannot reach the principal investigator or wish to talk to someone else, call the IRB office at 410-955-3008 .
If you are taking part at Sibley Memorial Hospital, call Dr.__________at insert telephone number .
If you are taking part at Suburban Hospital, call Dr. _______________at insert telephone number.

Protocol Version Date:
Page 6 of 8
If you are taking part at All Children’s Hospital, call Dr .____________
at insert telephone number.
c. W HAT SHOULD YOU DO IF YOU ARE INJURED OR ILL AS A RESULT OF BEING IN THIS STUDY ?
If you think you are injured or ill because of this study, call Principal Investigator (If the
Principal Investigator is not a medical doctor, include designated physician) at insert telephone number during regular office hours.
A 24 hour number must be included if the research is more than minimal risk to ensure participant has access to a physician for an urgent medical problem.
If you have an urgent medical problem related to your taking part in this study, call designated physician at insert telephone number during regular office hours and at insert phone or pager number available 24 hours after hours and on weekends.
If you insert a pager number, include the following instructions: After the tone, enter the phone number where you can be called, press the # key, and hang up.
If you are taking part at Sibley Memorial Hospital and you have a medical problem related to your taking part in this study, call Dr. ___________at insert telephone number.
If this doctor is not available, the operator will page the “on call physician.”
If you are taking part at Suburban Hospital and you have a medical problem related to your taking part in this study, call Dr.__________ at insert telephone number.
If this doctor is not available, the operator will page the “on call physician.”
If you ar e taking part at All Children’s Hospital and you have a medical problem related to your taking part in this study, call Dr. __________at insert telephone number. If this doctor is not available, the operator will page the “on call physician.” d. W HAT HAPPENS TO D ATA AND B IOSPECIMENS THAT ARE COLLECTED IN THE STUDY ?
If your study does not include biospecimens, you may delete that word from the heading and text
Johns Hopkins and our research partners work to understand and cure diseases. The biospecimens and/or data you provide are important to this effort.
If you join this study, you should understand that you will not own your biospecimens or data, and should researchers use them to create a new product or idea, you will not benefit financially.

Protocol Version Date:
If consent for biospecimens is part of this informed consent, include the following:
Page 7 of 8
With appropriate protections for privacy, Johns Hopkins may share your biospecimens and information with our research sponsors and partners. e. W HAT ARE THE O RGANIZATIONS THAT ARE PART OF J OHNS H OPKINS ?
Johns Hopkins includes the following:

The Johns Hopkins University

The Johns Hopkins Hospital

Johns Hopkins Bayview Medical Center

Howard County General Hospital

Johns Hopkins Community Physicians

Suburban Hospital

Sibley Memorial Hospital
 All Children’s Hospital
W HERE CAN I GET MORE INFORMATION ?
Visit the NCI's Web site at http://www.cancer.gov.
If you are in the United States, you may call the NCI's Cancer Information Service at:
1-800-4-CANCER (1-800-422-6237).
A DD THIS SECTION IF APPLICABLE TO YOUR STUDY
A DDITIONAL S TUDIES S ECTION
Indicate clearly to participants that this is a separate section

Protocol Version Date:
Page 8 of 8
What does your signature on this consent form mean?
Your signature on this form means that:

you understand the information given to you in this form

you accept the provisions in the form

you agree to allow your child to join the study
You and your child will not give up any legal rights by signing this consent form.
WE WILL GIVE YOU A COPY OF THIS SIGNED AND DATED CONSENT FORM
_________________________________________________________________________________________
Signature of Parent (Print Name) Date/Time
__________________________________________________________________________________________________
Signature of Person Obtaining Consent (Print Name)
Add any of the following that are applicable for this study and delete any that do not apply
Date/Time
__________________________________________________________________________________________________
Signature of Legally Authorized Representative (LAR) (Print Name) Date/Time
__________________________________________________________________________________________________
Description of LAR’s authority under Maryland Law to act as surrogate health care Date/Time decision-maker for child research participant (for example, Legal Guardian; Court-ordered representative)
__________________________________________________________________________________________________
Signature of Parent #2 (Print Name) Date/Time
(required if DHHS 45 CFR 46.406 or 46.407/FDA 21 CFR 50.53 or 50.54 study)
__________________________________________________________________________________________________
Signature of Child Participant (optional unless IRB required) (Print Name) Date/Time
___________________________________________________________________________________________________
Signature of Witness to Consent Procedures (Print Name)
(optional unless IRB or Sponsor required)
Date/Time
NOTE : A COPY OF THE SIGNED, DATED CONSENT FORM MUST BE KEPT BY THE PRINCIPAL
INVESTIGATOR; A COPY MUST BE GIVEN TO THE PARTICIPANT; IF YOU ARE USING EPIC
FOR THIS STUDY, A COPY MUST BE FAXED TO 410-367-7382; IF YOU ARE NOT USING EPIC,
A COPY MUST BE PLACED IN THE PARTICIPANT’S MEDICAL RECORD.
ONLY CONSENT FORMS THAT INCLUDE THE JOHNS HOPKINS MEDICINE LOGO CAN BE
USED TO OBTAIN THE CONSENT OF RESEARCH PARTICIPANTS. IF THIS CONSENT FORM
DOES NOT HAVE A JOHNS HOPKINS MEDICINE LOGO, DO NOT USE IT TO OBTAIN THE
CONSENT OF RESEARCH PARTICIPANTS